At the risk of being Captain Repetitive I have the same

New Post Public Reply Private Reply Replies (3) Message Board
Mo Mo #62541
604
At the risk of being Captain Repetitive I have the same question as yesterday. Did any investors (not stock traders) on this board sell any IPIX shares today? The answer of course is the same as yesterday. No investor in their right mind would sell at these compressed prices when any number of milestone achievements (including partnership deals for B-OM or B-IBD Oral or federal grant money and major Brilacidin orders for coronavirus treatment) would drive IPIX share price (SP) into the multi dollar range. With 8.631M shares supposedly sold yesterday and another 8.04M today, where the hell is the supply (sellers) coming from to complete these transactions? The criminal/NR underlings will wonder out loud if it is the MFO. First off, we don’t know if the MFO is selling any of their shares on the open market. Secondly, there was a total increase in IPIX Outstanding Shares from 6/30/19 thru 2/8/20 (over a 7 month timeframe) of 17.4M shares. Did the MFO sell as many shares in the last 2 days that IPIX’s entire OS increased in the past 7 months? The answer is of course NO. It is an absurd false narrative that tries to distract from the obvious. There is a major shortage of REAL SHARES on the supply or sell side. IPIX investors are Long and Strong as noted by the 90% FOR votes to increase Authorized Shares last fall and are holding tightly to their investment.

The answer is that VOLUME is mostly fake and the share price is controlled by the criminals/NR so therefore the SP is also fake. The SP is whatever the criminals/NR want it to be SHORT TERM. NR has been mostly successful for several years running IPIX SP from $2 up to almost $5 and then relentlessly and continuously down to 5 cents. The cost of capital for IPIX which is a pre-revenue biotech that is dependent on issuing stock to cover R&D and FDA trial expenses has continued to drastically increase. If NR could have put IPIX out of business it would have been a home-run for them. The problem for NR is that IPIX is not going out of business and even in the headwinds of major NR manipulation were able to advance their science to where we are today. So with NR’s problem of their target (IPIX) not going out of business and NR’s large exposure of their Naked Short Sale (NSS) position that has been built up over the past 6+ years combined with a lack of investors willing to part with their shares, what the hell is NR supposed to do? NR has dug themselves a very large hole. IMO NR is between a rock and a hard place regarding IPIX so their current plan is to explode volume using everything in their bag of tricks including wash trades and additional NSS to attempt to turn IPIX into a trading stock. For a stock to be a good trading stock you need 2 things #1 Volume and #2 Movement. This means NR has to manipulate both volume and price movement. NR has to hope that there are enough trading crews and some percentage of investor’s positions that will part with their shares and allow NR to grab some REAL SHARES of IPIX during these SP runs. Time is ticking on NR.

In the meantime investors should stay patient and add to their position if they are able. IMO investors should NOT hit the ASK as it plays into the criminals hand even though we are talking a half a cent or less. If investors split the bid/ask they will see first-hand how difficult it is for NR to unwillingly sell them shares that they don’t have. IPIX shareholders should not get too excited about the current fake volume and controlled fake SP (whether it goes up or down).

When IPIX completes a license deal for non-dilutive funds for B-OM and/or B-IBD oral and/or is awarded grant funding and order demand for Brilacidin for coronavirus treatment it is the beginning of the end of NR’s control over IPIX SP. This will be the beginning of a swing towards normal supply/demand valuation and IPIX SP will be in the dollars. 2020 should be a very profitable year once IPIX hits multiple milestones and we gain control back of our company.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 61

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 35

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 94

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 79

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 120

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Early Home Care Signals Families Should Not Ignore

Updated Category News Views 46

A pill organizer sitting untouched can say more than a family conversation ever will. Jay Mann of Amada Senior Care in Richmond points to a hard truth in HelloNation's Nov. 20, 2026 article: the need for in-home support often arrives quietly, disguised as little breaks in routines that everybody would rather wave away. This is not a matter for armchair diagnosis, and...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 31

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 60

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
.com/blog/news?page=2">More News Articles